Androgen-repressed phenotype in human prostate cancer
Open accessThe DOI matches its Crossref record.
Abstract
An androgen-repressed human prostate cancer cell line, ARCaP, was established and characterized. This cell line was derived from the ascites fluid of a patient with advanced metastatic disease. In contrast to the behavior of androgen-dependent LNCaP and its androgen-independent C4-2 subline, androgen and estrogen suppress the growth of ARCaP cells in a dose-dependent manner in vivo and in vitro . ARCaP is tumorigenic and highly metastatic. It metastasizes to the lymph node, lung, pancreas, liver, kidney, and bone, and forms ascites fluid in athymic hosts. ARCaP cells express low levels of androgen receptor mRNA and prostate-specific antigen mRNA and protein. Immunohistochemical staining shows that ARCaP cells stain intensely for epidermal growth factor receptor, c-erb B2/ neu , and c-erb B3. Staining is negative for chromogranin A and positive for bombesin, serotonin, neuron-specific enolase, and the c-met protooncogene (a hepatic growth factor/scatter factor receptor). ARCaP cells also secrete high levels of gelatinase A and B and some stromelysin, which suggests that this cell line may contain markers representing invasive adenocarcinoma with selective neuronendocrine phenotypes. Along with its repression of growth, androgen is also found to repress the expression of prostate-specific antigen in ARCaP cells as detected by a prostate-specific antigen promoter–β-galactosidase reporter assay. Our results suggest that the androgen-repressed state may be central to prostate cancer progression and that advanced prostate cancer can progress from an androgen-independent to an androgen-repressed state.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Molecular determinants of resistance to antiandrogen therapy
Chen, C. D., Welsbie, D. S., Tran, C., Baek, S. H., Chen, R., Vessella, R., Rosenfeld, M. G., & Sawyers, C. L. (2004) · Nature Medicine · doi:10.1038/nm972 · Cited by 2,278
“, and that androgen induces growth arrest or apoptosis in certain context”
BackgroundNanotechnology applications in cancer
Nie, S., Xing, Y., Kim, G. J., & Simons, J. W. (2007) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.9.060906.152025 · Cited by 952
Human prostate cancer risk factors
Bostwick, D. G., Burke, H. B., Djakiew, D., Euling, S., Ho, S.-M., Landolph, J., Morrison, H., Sonawane, B., Shifflett, T., Waters, D. J., et al. (2004) · Cancer · doi:10.1002/cncr.20408 · Cited by 650
Molecular characterization of human prostate carcinoma cell lines
van Bokhoven, A., Varella‐Garcia, M., Korch, C., Johannes, W. U., Smith, E. E., Miller, H. L., Nordeen, S. K., Miller, G. J., & Lucia, M. S. (2003) · The Prostate · doi:10.1002/pros.10290 · Cited by 633
Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry
Xing, Y., Chaudry, Q., Shen, C., Kong, K. Y., Zhau, H. E., Chung, L. W., Petros, J. A., O'Regan, R. M., Yezhelyev, M. V., Simons, J. W., et al. (2007) · Nature Protocols · doi:10.1038/nprot.2007.107 · Cited by 528
Self-citationCulig, Z., Hoffmann, J., Erdel, M., Eder, I. E., Hobisch, A., Hittmair, A., Bartsch, G., Utermann, G., Schneider, M. R., Parczyk, K., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690684 · Cited by 409
LNCaP progression model of human prostate cancer: Androgen-independence and osseous metastasis
Thalmann, G. N., Sikes, R. A., Wu, T. T., Degeorges, A., Chang, S.-M., Ozen, M., Pathak, S., & Chung, L. W. K. (2000) · The Prostate · doi:10.1002/1097-0045(20000701)44:2<91::aid-pros1>3.0.co;2-l · Cited by 366
Self-citationCELL LINES USED IN PROSTATE CANCER RESEARCH: A COMPENDIUM OF OLD AND NEW LINES—PART 1
SOBEL, R. E., & SADAR, M. D. (2005) · Journal of Urology · doi:10.1097/01.ju.0000141580.30910.57 · Cited by 364
MOLECULAR INSIGHTS INTO PROSTATE CANCER PROGRESSION: THE MISSING LINK OF TUMOR MICROENVIRONMENT
CHUNG, L. W. K., BASEMAN, A., ASSIKIS, V., & ZHAU, H. E. (2005) · Journal of Urology · doi:10.1097/01.ju.0000141582.15218.10 · Cited by 361
Self-citationNear IR Heptamethine Cyanine Dye–Mediated Cancer Imaging
Yang, X., Shi, C., Tong, R., Qian, W., Zhau, H. E., Wang, R., Zhu, G., Cheng, J., Yang, V. W., Cheng, T., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0059 · Cited by 302
Self-citationAgus, D. B., Cordon-Cardo, C., Fox, W., Drobnjak, M., Koff, A., Golde, D. W., & Scher, H. I. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.21.1869 · Cited by 248
Wu, J., Ivanov, A. I., Fisher, P. B., & Fu, Z. (2016) · eLife · doi:10.7554/elife.10734 · Cited by 117
“ARCaP cells were derived from the ascites fluid of an 83-year-old Caucasian man diagnosed with metastatic carcinoma of the prostate (Zhau et al., 1996).”
MethodAndrogen axis in prostate cancer.
Culig, Z., & Bartsch, G. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20898 · Cited by 102
Widely used prostate carcinoma cell lines share common origins
van Bokhoven, A., Varella‐Garcia, M., Korch, C., Hessels, D., & Miller, G. J. (2001) · The Prostate · doi:10.1002/pros.1045 · Cited by 90
Spectral karyotype (SKY) analysis of human prostate carcinoma cell lines
van Bokhoven, A., Caires, A., Maria, M. D., Schulte, A. P., Lucia, M. S., Nordeen, S. K., Miller, G. J., & Varella‐Garcia, M. (2003) · The Prostate · doi:10.1002/pros.10291 · Cited by 56
BK Ca Channels Activating at Resting Potential without Calcium in LNCaP Prostate Cancer Cells
Gessner, G., Schönherr, K., Soom, M., Hansel, A., Asim, M., Baniahmad, A., Derst, C., Hoshi, T., & Heinemann, S. H. (2006) · The Journal of Membrane Biology · doi:10.1007/s00232-005-0830-z · Cited by 55
“C4-2 cells (kindly provided by G. Thalmann) were maintained in 10% FCScontaining T-medium (Zhau et al., 1996).”
MethodDang, X., Singh, A., Spetman, B. D., Nolan, K. D., Isaacs, J. S., Dennis, J. H., Dalton, S., Marshall, A. G., & Young, N. L. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00414 · Cited by 41
Metadata
- Authors
- Zhau, H. Y. E., Chang, S.-M., Chen, B.-Q., Wang, Y., Zhang, H., Kao, C., Sang, Q. A., Pathak, S. J., & Chung, L. W. K.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-12-24
- Volume
- 93
- Issue
- 26
- Pages
- 15152-15157
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2080989291
- Cited by
- 231
- References
- 0
- FWCI
- 8.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.